Literature DB >> 19960256

Lactobacillus plantarum prevents the upregulation of adhesion molecule expression in an experimental colitis model.

Zhao-Xin Chu1, Hong-Qi Chen, Yan-Lei Ma, Yu-Kun Zhou, Ming Zhang, Peng Zhang, Huan-Long Qin.   

Abstract

BACKGROUND: Lactobacillus consumption has been shown to attenuate the severity of experimental colitis. Whether the effects of Lactobacillus on colitis are related to modulation of leukocyte recruitment into the inflamed intestine is unclear. AIMS: To investigate the effect of Lactobacillus plantarum daily intragastric administration on lymphocyte homing and intestinal inflammation in interleukin 10 (IL-10) knockout mice, an experimental model of colitis.
METHODS: Two groups of ten IL-10 knockout mice were fed phosphate buffered saline containing Lactobacillus plantarum 1258 or unmodified vehicle for 4 weeks. Two groups of ten wild-type mice were used as controls. At killing, the bowels were histologically scored and evaluated by transmission electron microscopy. Mucosal addressin cell adhesion molecule 1 (MAdCAM-1) and intercellular adhesion molecule 1 (ICAM-1) expression were determined by immunohistochemistry. The levels of proinflammatory cytokines, tumor necrosis factor alpha (TNF-alpha), and interferon gamma (IFN-gamma) were determined by ELISA. In addition, levels of CD3, alpha4beta7, ICAM-1, and MAdCAM-1 were determined by reverse-transcription polymerase chain reaction and Western blot.
RESULTS: L. plantarum treatment improved the histological damage score in KO mice compared to untreated KO mice. L. plantarum significantly attenuated the expression of MAdCAM-1, ICAM-1, CD3, and alpha4beta7, but did not affect the levels of TNF-alpha and IFN-gamma when treated KO mice were compared to untreated KO mice.
CONCLUSIONS: L. plantarum interfered with the upregulation of adhesion molecules observed in IL-10 knockout mice compared to wild-type mice, attenuating the symptoms of colitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19960256     DOI: 10.1007/s10620-009-1063-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  44 in total

1.  Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.

Authors:  P Gionchetti; F Rizzello; A Venturi; P Brigidi; D Matteuzzi; G Bazzocchi; G Poggioli; M Miglioli; M Campieri
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

Review 2.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

Review 3.  The lymphocyte homing receptors: gatekeepers of the multistep paradigm.

Authors:  Robert Sackstein
Journal:  Curr Opin Hematol       Date:  2005-11       Impact factor: 3.284

Review 4.  Probiotic effects on inflammatory bowel disease.

Authors:  Barbara Sheil; Fergus Shanahan; Liam O'Mahony
Journal:  J Nutr       Date:  2007-03       Impact factor: 4.798

Review 5.  The highway code of T cell trafficking.

Authors:  F M Marelli-Berg; L Cannella; F Dazzi; V Mirenda
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

6.  Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers.

Authors: 
Journal:  J Travel Med       Date:  1997-03-01       Impact factor: 8.490

Review 7.  In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings.

Authors:  C Dunne; L O'Mahony; L Murphy; G Thornton; D Morrissey; S O'Halloran; M Feeney; S Flynn; G Fitzgerald; C Daly; B Kiely; G C O'Sullivan; F Shanahan; J K Collins
Journal:  Am J Clin Nutr       Date:  2001-02       Impact factor: 7.045

8.  Probiotic bacteria enhance murine and human intestinal epithelial barrier function.

Authors:  K Madsen; A Cornish; P Soper; C McKaigney; H Jijon; C Yachimec; J Doyle; L Jewell; C De Simone
Journal:  Gastroenterology       Date:  2001-09       Impact factor: 22.682

Review 9.  Antiadhesion molecule therapy in inflammatory bowel disease.

Authors:  Gert van Assche; Paul Rutgeerts
Journal:  Inflamm Bowel Dis       Date:  2002-07       Impact factor: 5.325

10.  Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance.

Authors:  J McCarthy; L O'Mahony; L O'Callaghan; B Sheil; E E Vaughan; N Fitzsimons; J Fitzgibbon; G C O'Sullivan; B Kiely; J K Collins; F Shanahan
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

View more
  11 in total

1.  Protective effects of Lactobacillus plantarum against epithelial barrier dysfunction of human colon cell line NCM460.

Authors:  Zhi-Hua Liu; Tong-Yi Shen; Peng Zhang; Yan-Lei Ma; Mary Pat Moyer; Huan-Long Qin
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

Review 2.  Basic and clinical research on the regulation of the intestinal barrier by Lactobacillus and its active protein components: a review with experience of one center.

Authors:  Zhi-Hua Liu; Liang Kang; Jian-Ping Wang
Journal:  Mol Biol Rep       Date:  2014-09-04       Impact factor: 2.316

Review 3.  The role and pathophysiological relevance of membrane transporter PepT1 in intestinal inflammation and inflammatory bowel disease.

Authors:  Sarah A Ingersoll; Saravanan Ayyadurai; Moiz A Charania; Hamed Laroui; Yutao Yan; Didier Merlin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-22       Impact factor: 4.052

4.  MyD88 mediates the protective effects of probiotics against the arteriolar thrombosis and leukocyte recruitment associated with experimental colitis.

Authors:  Daniele G Souza; Elena Y Senchenkova; Janice Russell; D Neil Granger
Journal:  Inflamm Bowel Dis       Date:  2015-04       Impact factor: 5.325

Review 5.  New perspectives of Lactobacillus plantarum as a probiotic: The gut-heart-brain axis.

Authors:  Yen-Wenn Liu; Min-Tze Liong; Ying-Chieh Tsai
Journal:  J Microbiol       Date:  2018-08-23       Impact factor: 3.422

6.  Modulation of anti-inflammatory response in lipopolysaccharide stimulated human THP-1 cell line and mouse model at gene expression level with indigenous putative probiotic lactobacilli.

Authors:  V Aparna Sudhakaran; Harsh Panwar; Ritu Chauhan; Raj Kumar Duary; Rahul Kumar Rathore; Virender Kumar Batish; Sunita Grover
Journal:  Genes Nutr       Date:  2013-06-02       Impact factor: 5.523

Review 7.  Nutritional modulators of ulcerative colitis: clinical efficacies and mechanistic view.

Authors:  Mi-Kyung Sung; Mi-Young Park
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

8.  Effect of Synbiotic and Probiotic Supplementation on Serum Levels of Endothelial Cell Adhesion Molecules in Hemodialysis Patients: a Randomized Control Study.

Authors:  Neda Haghighat; Majid Mohammadshahi; Shokouh Shayanpour; Mohammad Hossein Haghighizadeh
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

9.  Effects of Lactobacillus curvatus MG5246 on inflammatory markers in Porphyromonas gingivalis lipopolysaccharide-sensitized human gingival fibroblasts and periodontitis rat model.

Authors:  Jae-In Jung; Yong Gyeong Kim; Chang-Ho Kang; Jee-Young Imm
Journal:  Food Sci Biotechnol       Date:  2021-11-26       Impact factor: 2.391

10.  Probiotics, symptoms, and gut microbiota: what are the relations? A randomized controlled trial in subjects with irritable bowel syndrome.

Authors:  Per G Farup; Morten Jacobsen; Solveig C Ligaarden; Knut Rudi
Journal:  Gastroenterol Res Pract       Date:  2012-07-31       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.